title: [Choosing combined or complex treatment approach in oral SCC patients].
abstract: The aim was to determine the different regiments of adjuvant therapy after radical surgery in patients with oral cancer based on the prognostic factors. 2-years disease-free survival in group with adjuvant chemoradiotherapy was 71.4%; in the adjuvant radiotherapy group - 66.2%. The neoadjuvant chemoradiotherapy demonstrated only 57% 2-years disease-free survival. Our results demonstrate that adjuvant radiotherapy or chemoradiotherapy combined with cisplatin is more effective in treatment of the patients with oral cancer.
authors.forename: E G
authors.initials: EG
authors.lastname: Matiakin
authors.forename: L P
authors.initials: LP
authors.lastname: Iakovleva
authors.forename: I S
authors.initials: IS
authors.lastname: Romanov
authors.forename: A I
authors.initials: AI
authors.lastname: Pavlovskaia
authors.forename: V T
authors.initials: VT
authors.lastname: Tsiklauri
authors.forename: M G
authors.initials: MG
authors.lastname: Dzhumaev
mesh_terms: D002294:Carcinoma, Squamous Cell / Q000401:mortality / Q000473:pathology / Q000628:therapy*; D059186:Chemoradiotherapy, Adjuvant / Q000379:methods*; D002945:Cisplatin / Q000627:therapeutic use; D018572:Disease-Free Survival; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009062:Mouth Neoplasms / Q000401:mortality / Q000473:pathology / Q000628:therapy*; D020360:Neoadjuvant Therapy / Q000379:methods*; D016896:Treatment Outcome
chemical_list: D002945:Cisplatin